Jean-Yves Pierga

Jean-Yves Pierga

UNVERIFIED PROFILE

Are you Jean-Yves Pierga?   Register this Author

Register author
Jean-Yves Pierga

Jean-Yves Pierga

Publications by authors named "Jean-Yves Pierga"

Are you Jean-Yves Pierga?   Register this Author

100Publications

4041Reads

12Profile Views

Interaction between molecular subtypes, stromal immune infiltration before and after treatment in breast cancer patients treated with neoadjuvant chemotherapy.

Clin Cancer Res 2019 Sep 12. Epub 2019 Sep 12.

Translational Research Department, INSERM,U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France, Institut Curie, PSL Research University

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-3017DOI Listing
September 2019

ERBB3 mutations in cancer: biological aspects, prevalence and therapeutics.

Oncogene 2019 Sep 13. Epub 2019 Sep 13.

Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41388-019-1001-5DOI Listing
September 2019

ESR1 mutations: a new biomarker in breast cancer.

Expert Rev Mol Diagn 2019 Jul 19;19(7):599-611. Epub 2019 Jun 19.

a Department of Medical Oncology , Institut Curie, PSL Research University , Saint Cloud , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14737159.2019.1631799DOI Listing
July 2019

Circulating Tumor Cells in Early Breast Cancer.

JNCI Cancer Spectr 2019 Jun 27;3(2):pkz026. Epub 2019 Apr 27.

Department of Medical Oncology, Institut Curie, Paris and Saint Cloud, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncics/pkz026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6649836PMC
June 2019

Disseminated Tumor Cells Predict Efficacy of Regional Nodal Irradiation in Early Stage Breast Cancer.

Int J Radiat Oncol Biol Phys 2019 02 4;103(2):389-396. Epub 2018 Oct 4.

Department of Medical Oncology, Institut Curie, PSL Research University, Paris and Saint Cloud, France; Circulating Tumor Biomarkers Laboratory, Siric, Institut Curie, PSL Research University, Paris, France; UVSQ, Paris Saclay University, Paris, France.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03603016183381
Publisher Site
http://dx.doi.org/10.1016/j.ijrobp.2018.09.033DOI Listing
February 2019

Clinical potential of circulating tumour DNA in patients receiving anticancer immunotherapy.

Nat Rev Clin Oncol 2018 10;15(10):639-650

Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-018-0074-3DOI Listing
October 2018

Lymphovascular invasion after neoadjuvant chemotherapy is strongly associated with poor prognosis in breast carcinoma.

Breast Cancer Res Treat 2018 Jun 27;169(2):295-304. Epub 2018 Jan 27.

Translational Research Department, INSERM, U932, Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory, RT2Lab, Institut Curie, PSL Research University, 26, rue d'Ulm, 75248, Paris, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-017-4610-0
Publisher Site
http://dx.doi.org/10.1007/s10549-017-4610-0DOI Listing
June 2018

Cdk4/6 inhibitors and overall survival: power of first-line trials in metastatic breast cancer.

NPJ Breast Cancer 2018 26;4:14. Epub 2018 Jun 26.

2Department of Medical Oncology, Institut Curie, PSL Research University, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41523-018-0068-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018749PMC
June 2018

FISH-in-CHIPS: A Microfluidic Platform for Molecular Typing of Cancer Cells.

Methods Mol Biol 2017 ;1547:211-220

Macromolecules and Microsystems in Biology and Medicine, Institut Curie, Centre National de la Recherche Scientifique, Université Pierre et Marie Curie, PSL Research University, UMR 168, 75005, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-6734-6_16DOI Listing
February 2018

Multiple Hotspot Mutations Scanning by Single Droplet Digital PCR.

Clin Chem 2018 02 9;64(2):317-328. Epub 2017 Nov 9.

Circulating Tumor Biomarkers Laboratory, SiRIC, Translational Research Department, Institut Curie, PSL Research University, Paris, France;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1373/clinchem.2017.272518DOI Listing
February 2018

RECIST response and variation of circulating tumour cells in phase 1 trials: A prospective multicentric study.

Eur J Cancer 2017 09 22;83:185-193. Epub 2017 Jul 22.

Drug Development Department (DITEP), Gustave Roussy, 94805, Villejuif, France; Université Paris-Sud, Faculté de Médecine, Université Paris-Saclay, Orsay, 91405, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2017.05.016DOI Listing
September 2017

[Internal quality control on HER2 status determination in breast cancers: Experience of a cancer center].

Bull Cancer 2017 Jul - Aug;104(7-8):608-617. Epub 2017 Jun 7.

Institut Curie, service d'anatomie et de cytologie pathologiques, 26, rue d'Ulm, 75005 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.05.002DOI Listing
August 2017

Circulating tumor cells: clinical validity and utility.

Int J Clin Oncol 2017 Jun 25;22(3):421-430. Epub 2017 Feb 25.

Department of Medical Oncology, Institut Curie, PSL Research University, 26 rue d'Ulm, 75005, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-017-1105-2DOI Listing
June 2017

San Antonio 2016: Progress on the Long Way to Individualized Treatment of Breast Cancer.

Breast Care (Basel) 2017 Mar 28;12(1):54-58. Epub 2017 Feb 28.

Brustzentrum am UKE, Kompetenzzentrum für familiären Brust- und Eierstockkrebs, Klinik und Poliklinik für Gynäkologie, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000458749DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5465780PMC
March 2017

Rate of Distant Metastases on 18F-FDG PET/CT at Initial Staging of Breast Cancer: Comparison of Women Younger and Older Than 40 Years.

J Nucl Med 2017 02 1;58(2):252-257. Epub 2016 Sep 1.

Service de Médecine Nucléaire, Institut Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.116.178749DOI Listing
February 2017

Circulating tumor DNA for triple-negative breast cancer diagnosis and treatment decisions.

Expert Rev Mol Diagn 2016 9;16(1):39-50. Epub 2015 Dec 9.

a Institut Curie , PSL Research University , Paris , France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737159.2016.1121100DOI Listing
October 2016

70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer.

N Engl J Med 2016 Aug;375(8):717-29

From Champalimaud Clinical Center-Champalimaud Foundation, Lisbon, Portugal (F.C.); Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco (L.J.V.); European Organization for Research and Treatment of Cancer Headquarters (J.B., L. Slaets, V.G., B.M., K.T.), Breast International Group Headquarters (T.G., C. Straehle), and Institut Jules Bordet, Université Libre de Bruxelles (C. Sotiriou, M.P.), Brussels, and Centre Hospitalier Universitaire Université Catholique de Louvain, Namur (P.V.) - both in Belgium; University of Milan and Istituto Europeo di Oncologia (G.V.) and Europa Donna-European Breast Cancer Coalition (S.K.), Milan, and Azienda Istituti Ospitalieri di Cremona, Cremona (R.P.) - both in Italy; Gustave Roussy, Villejuif (S.D., M.S.), Institut Curie Paris Sciences et Lettres, Université Paris Descartes, Sorbonne Paris Cité, Paris (J.-Y.P.). Institut Curie-Hôpital Rene Huguenin, Saint-Cloud (E.B.), and Centre Georges-Francois-Leclerc, Dijon (S.C.) - all in France; Swiss Institute of Bioinformatics and University of Lausanne, Lausanne, Switzerland (M.D.); Agendia (A.M.G., L. Stork) and the Netherlands Cancer Institute (R.B., E.R.), Amsterdam, Alrijne Ziekenhuis, Rijnland Leiderdorp (P.A.N.), Jeroen Bosch Hospital, 's-Hertogenbosch (T.J.S.), and Medisch Centrum Alkmaar, Alkmaar (J.M.H.) - all in the Netherlands; Institute of Oncology, Ljubljana, Slovenia (E.M.); Evangelisches Krankenhaus Bethesda, Duisburg, Germany (U.N.); University of Texas Health Sciences Center, San Antonio (P.R.); Hospital Universitario Vall d'Hebron, Barcelona (I.T.R.); Imperial College London, London (G.T.); and University of Texas M.D. Anderson Cancer Center, Houston (A.M.T.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1602253DOI Listing
August 2016

Impact of Adjuvant Chemotherapy on Breast Cancer Survival: A Real-World Population.

PLoS One 2015 27;10(7):e0132853. Epub 2015 Jul 27.

Institut Curie, Paris, France; Equipe d'Accueil 7285, Risk and safety in clinical medicine for women and perinatal health, University Versailles-Saint-Quentin, Montigny-le-Bretonneux, France.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132853PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516355PMC
May 2016

Circulating tumor cells in breast cancer.

Mol Oncol 2016 Mar 12;10(3):418-30. Epub 2016 Jan 12.

Institut Curie, PSL Research University, SiRIC, Laboratory of Circulating Tumor Biomarkers, Paris, France; Institut Curie, PSL Research University, Department of Medical Oncology, Paris, France; Université Paris Descartes, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2016.01.001DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528978PMC
March 2016

Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer.

Mol Oncol 2016 Mar 22;10(3):481-93. Epub 2016 Jan 22.

Institut Curie, PSL Research University, SiRIC, Laboratory of Circulating Tumor Biomarkers, Paris, France; Institut Curie, PSL Research University, Department of Medical Oncology, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2016.01.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528974PMC
March 2016

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort.

Br J Cancer 2016 01 10;114(1):44-52. Epub 2015 Dec 10.

Institut Curie, PSL Research University, Translational Research Department, INSERM, U932 Immunity and Cancer, Residual Tumor & Response to Treatment Laboratory (RT2Lab), F-75248, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bjc.2015.426DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4716543PMC
January 2016

High purity microfluidic sorting and analysis of circulating tumor cells: towards routine mutation detection.

Lab Chip 2015 May;15(9):2090-101

Institut Curie, Centre National de la Recherche Scientifique, Université Pierre et Marie Curie, PSL Research University, Unité Mixte de Recherche 168, 75005 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c5lc00104hDOI Listing
May 2015

Clinical utility of circulating tumor cells in metastatic breast cancer.

J Clin Oncol 2015 May 13;33(14):1622. Epub 2015 Apr 13.

Institut Curie; Université Paris Descartes, Paris, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.57.9714DOI Listing
May 2015

Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types.

Mol Oncol 2015 Apr 26;9(4):783-90. Epub 2014 Dec 26.

Circulating Cancer Biomarkers Lab, SiRIC, Translational Research Department, Institut Curie, Paris, France; Department of Medical Oncology, Institut Curie, Paris and Saint-Cloud, France; University Paris Descartes, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2014.12.003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528781PMC
April 2015

FISH in chips: turning microfluidic fluorescence in situ hybridization into a quantitative and clinically reliable molecular diagnosis tool.

Lab Chip 2015 Feb;15(3):811-22

Macromolecules and Microsystems in Biology and Medicine, Institut Curie, Centre National de Recherche Scientifique, Université Pierre et Marie Curie, UMR 168, 75005 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1039/c4lc01059kDOI Listing
February 2015

Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma.

Int J Cancer 2014 Mar 3;134(5):1207-13. Epub 2013 Sep 3.

Department of Medical Oncology, Institut Curie, Paris, France; Laboratory of Circulating Tumor Biomarkers, Institut Curie, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.28436DOI Listing
March 2014

[Circulating tumor cells: liquid biopsy].

Bull Cancer 2014 Jan;101(1):17-23

Laboratoire des biomarqueurs circulants, SIRIC et département d'oncologie médicale de l'Institut Curie, 26, rue d'Ulm, 75005 Paris, France, Université Paris-Descartes, 12, rue de l'École-de-Médecine, 75270 Paris Cedex 06, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2014.1883DOI Listing
January 2014

[Breast cancer: major therapeutic advances but mortality remains high].

Authors:
Jean-Yves Pierga

Rev Prat 2013 Dec;63(10):1359-61

Département d'oncologie médicale, Institut Curie, 75005 Paris, université Paris Descartes, 75006 France, France.

View Article

Download full-text PDF

Source
December 2013

Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study.

Int J Breast Cancer 2013 9;2013:130470. Epub 2013 May 9.

Department of Medical Oncology, Institut Curie, 26 rue d'Ulm, 75005 Paris, France ; Laboratory of Circulating Cancer Biomarker, Institut Curie, 26 rue d'Ulm, 75005 Paris, France.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/ijbc/2013/130470/
Publisher Site
http://dx.doi.org/10.1155/2013/130470DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3665249PMC
June 2013

Translating metastasis-related biomarkers to the clinic--progress and pitfalls.

Nat Rev Clin Oncol 2013 Mar 5;10(3):169-79. Epub 2013 Feb 5.

Department of Medical Oncology, Institut Curie & Université Paris Descartes, 26 rue d'Ulm, 75005 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2013.4DOI Listing
March 2013

Microfluidic: an innovative tool for efficient cell sorting.

Methods 2012 Jul 11;57(3):297-307. Epub 2012 Jul 11.

Institut Curie, Centre National de la Recherche Scientifique, Université Pierre et Marie Curie, Unité Mixte de Recherche 168, 75005 Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ymeth.2012.07.002DOI Listing
July 2012

Safety of bevacizumab in metastatic breast cancer patients undergoing surgery.

Eur J Cancer 2012 Mar 22;48(4):475-81. Epub 2011 Dec 22.

Department of Oncology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2011.11.021DOI Listing
March 2012